FDA panel mulls over Covid booster issues despite ‘insufficient data’

Source:

The following is an excerpt from MedPage. All the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about on Wednesday in terms of a plan for Covid boosters is that they need more data. FDA staff charged VRBPAC members with discussing what considerations should inform strain composition decisions for Covid boosters, how often should […]

Continue reading FDA panel mulls over Covid booster issues despite ‘insufficient data’ on sharylattkisson.com.

0 0 votes
Article Rating

Follow Sharyl Attkisson on:

VIEW MORE FROM Sharyl Attkisson

Support Sharyl Attkisson

Order the New York Times bestseller “The Smear” today online or borrow from your library

FULL MEASURE NEWS

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments